Kane Matthew

BE·FSMA

Celyad Oncology

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 28 Nov 2024 for CELYAD ONCOLOGY, €280k. Read the official filing

Kane Matthew: trading record in brief

One trade, one date: on 28 November 2024, Kane Matthew disclosed a transaction of €280k in Celyad Oncology. No broader history exists yet. This summary is built from FSMA disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kane Matthew

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Celyad Oncology (BE)

Declarations1 total

●

Kane Matthew

Member of administrative management or supervisory bodyExecutives28 Nov 2024Celyad Oncology

€280k15FSMA ↗

1,035,714 shares@ €0.27100.0% of flowOptions /warrants for employees or managersOff exchangeBE0974260896FSMA:celyad-oncology-2

1 of 1 declaration

Kane Matthew

Kane Matthew: trading record in brief

Companies and markets linked to Kane Matthew

Related entities

Kane Matthew

Kane Matthew: trading record in brief

Companies and markets linked to Kane Matthew

Related entities